Raymond James Financial Services Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Raymond James Financial Services Advisors's NEO Position: Q1 2022 in Review
Raymond James Financial Services Advisors sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 100,894 shares — an estimated $3.44M sold.
Raymond James Financial Services Advisors first reported a position in NEO in Q3 2018 and held it in 13 quarters. The position peaked at $5.99M in Q4 2020. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- Raymond James Financial Services Advisors reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 100,894 NeoGenomics shares in Q1 2022, an estimated $3.44M.
- Raymond James Financial Services Advisors first reported a position in NeoGenomics in Q3 2018 and held it in 13 quarters.
- Raymond James Financial Services Advisors's NeoGenomics position peaked at $5.99M in Q4 2020.
- 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on Raymond James Financial Services Advisors's 13F filing for Q1 2022, filed 11 May 2022.